Cargando...
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
Since 1989, four Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia (CCCDTDs) have provided evidence‐based dementia diagnostic and treatment guidelines for Canadian clinicians and researchers. We present the results from the Neuroimaging and Fluid Biomarkers Group of the 5th C...
Guardado en:
| Publicado en: | Alzheimers Dement (N Y) |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821956/ https://ncbi.nlm.nih.gov/pubmed/33532543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12098 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|